Related Experiment Video

Updated: Mar 4, 2026

Quantitative Microtubule Fractionation Technique to Separate Stable Microtubules, Labile Microtubules, and Free Tubulin in Mouse Tissues
07:21

Quantitative Microtubule Fractionation Technique to Separate Stable Microtubules, Labile Microtubules, and Free Tubulin in Mouse Tissues

Published on: November 17, 2023

2.8K

Potential mechanisms of resistance to microtubule inhibitors

Maria Kavallaris1, Jean-Philippe Annereau, Jean-Marc Barret

  • 1Children's Cancer Institute Australia for Medical Research, High Street, 2031 Randwick, NSW, Australia.

Seminars in Oncology
|August 9, 2008
PubMed

Insights

Antimitotic drugs like taxanes and vinca alkaloids fight cancer but face drug resistance. Vinflunine, a new microtubule inhibitor, shows promise with a different resistance pattern, offering potential new cancer treatment options.

Area of Science:

  • Pharmacology
  • Oncology
  • Cell Biology

Background:

  • Antimitotic drugs, including taxanes and vinca alkaloids, are crucial in treating neoplastic diseases by targeting microtubules.
  • Drug resistance to these agents limits their long-term efficacy and presents a significant clinical challenge.
  • Understanding resistance mechanisms is vital for developing improved therapeutic strategies.

Purpose of the Study:

  • To investigate the potential of vinflunine, a novel microtubule inhibitor, as a therapeutic option.
  • To characterize the resistance profile of vinflunine in comparison to existing vinca alkaloids.

Main Methods:

  • Preclinical evaluation of vinflunine's antitumor activity.
  • Comparative analysis of drug resistance patterns between vinflunine and other vinca alkaloids.

Main Results:

  • Vinflunine demonstrated superior preclinical antitumor activity.
  • Vinflunine exhibited a distinct pattern of drug resistance compared to other agents in the vinca alkaloid class.

Conclusions:

  • Vinflunine represents a promising novel microtubule inhibitor for cancer treatment.
  • Its unique resistance profile may offer a way to overcome existing therapeutic limitations.

More Related Videos

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers06:02

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

8.0K
Preparation of Segmented Microtubules to Study Motions Driven by the Disassembling Microtubule Ends12:20

Preparation of Segmented Microtubules to Study Motions Driven by the Disassembling Microtubule Ends

Published on: March 15, 2014

15.0K

Related Concept Videos

Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.8K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.2K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
6.3K
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
6.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K